Furthermore, the authors, using a highly selective, non-permeant CtsB inhibitor, demonstrated that the extracellular activity of CtsB is key in promoting cancer cell migration and invasion, thus revealing a non-canonical, extralysosomal activity for CtsB in colorectal cancer metastasis [236]. This evidence concerns the gene CTSB and colorectal cancer.